Erica Silk
Dermatology · Springfield, MANPI 1821645649
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $368 of the $586 with a category attached, or 62.8%. 11 manufacturers reported payments, led by Johnson & Johnson at 25.0% of the total. That places this record below the midpoint for dermatology clinicians in MA, where the typical reported total is $979.
Across 28 payments — averaging $20.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$147
- AbbVie$138
- Sanofi-aventis U.S. LLC$85
- Incyte Corporation$64
- Regeneron Healthcare Solutions, Inc.$49
- Novartis$25
- plus $78 from 5 others
What the payments were for
- Food & beverage$36863%
- Education$21837%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 3 | $147 |
| AbbVie | 13 | $138 |
| Sanofi-aventis U.S. LLC | 1 | $85 |
| Incyte Corporation | 3 | $64 |
| Regeneron Healthcare Solutions, Inc. | 2 | $49 |
| Novartis | 1 | $25 |
| Arcutis Biotherapeutics, Inc. | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Pfizer | 1 | $16 |
| Sun Pharmaceutical Industries Inc. | 1 | $16 |
| Organon | 1 | $11 |
How this compares
$586 in reported general payments places this provider in the 40th percentile of 552 dermatology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OtezlaApremilast | 23 | $123,010 |
| Dupixent PenDupilumab | 14 | $52,389 |
| Clobetasol Propionate | 60 | $3,175 |
| Tacrolimus | 19 | $2,770 |
| Metronidazole | 64 | $2,372 |
| Calcipotriene | 17 | $2,065 |
| Ketoconazole | 124 | $2,021 |
| Fluocinonide | 28 | $1,355 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 20 | $1,226 |
| Clindamycin Phosphate | 17 | $847 |
| Triamcinolone Acetonide | 78 | $817 |
| Betamethasone Dipropionate | 16 | $652 |
| Fluorouracil | 11 | $570 |
| Nystatin | 20 | $403 |
| Mupirocin | 48 | $384 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Springfield
- John HarrisWorcester$15M
- Ethan LernerCharlestown$1.7M
- Michael KaminerChestnut Hill$1.1M
- Jeffrey SobellChestnut Hill$986K
- Erik DominguesFall River$736K
- Alexandra KimballBoston$680K
- Arash MostaghimiBoston$591K
- David GreensteinBeverly$540K
- Brian HiblerBoston$498K
- Maryanne SennaBoston$430K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.